Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS

Pancreatology

Volumn 12, Issue 2, 2012, Pages 124-129

  Xue, Aiqun ^a   Gandy, Robert C ^a   Chung, Liping ^a   Baxter, Robert C ^a   Smith, Ross C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Biomarkers; Diagnosis; Immunodepletion; Pancreatic neoplasms; Serum proteome

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 84862799580     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2012.02.009     Document Type: Article

References (20)

1. Honda K, Hayashida Y, Umaki T, Okusaka T, Kosuge T, Kikuchi S, et al. Possible detection of pancreatic cancer by plasma protein profiling. Cancer Res 2005; 65(22):10613-22. (Pubitemid 41743757)
2. Koopmann J, Zhang Z, White N, Rosenzweig J, Fedarko N, Jagannath S, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 2004;10(3): 860-8. (Pubitemid 38198884)
3. Rosty C, Goggins M. Early detection of pancreatic carcinoma. Hematol Oncol Clin North Am 2002;16(1):37-52. (Pubitemid 34578625)
4. Yu Y, Chen S, Wang LS, Chen WL, Guo WJ, Yan H, et al. Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncology 2005; 68(1):79-86. (Pubitemid 40675013)
5. Conrads TP, Hood BL, Issaq HJ, Veenstra TD. Proteomic patterns as a diagnostic tool for early-stage cancer: a review of its progress to a clinically relevant tool. Mol Diagn 2004;8(2):77-85. (Pubitemid 39363461)
6. Ehmann M, Felix K, Hartmann D, Schnolzer M, Nees M, Vorderwulbecke S, et al. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas 2007; 34(2):205-14. (Pubitemid 46294796)
7. Fiedler GM, Leichtle AB, Kase J, Baumann S, Ceglarek U, Felix K, et al. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Clin Cancer Res 2009;15(11): 3812-9.
8. Guo J, Wang W, Liao P, Lou W, Ji Y, Zhang C, et al. Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis. Cancer Sci; 2009.
9. Takano S, Yoshitomi H, Togawa A, Sogawa K, Shida T, Kimura F, et al. Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells. Oncogene 2008;27(20):2810-22. (Pubitemid 351620452)
10. Xue A, Scarlett CJ, Chung L, Butturini G, Scarpa A, Gandy R, et al. Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis. Br J Cancer 2010;103(3):391-400.
11. Kawada N. Cancer serum proteomics in gastroenterology. Gastroenterology 2006;130(6):1917-9. (Pubitemid 43668845)
12. Tu C, Rudnick PA, Martinez MY, Cheek KL, Stein SE, Slebos RJ, et al. Depletion of abundant plasma proteins and limitations of plasma proteomics. J Proteome Res 2010;9(10):4982-91.
13. Ernoult E, Bourreau A, Gamelin E, Guette C. A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation. J Biomed Biotechnol 2010;2010:927917.
14. Ye H, Sun L, Huang X, Zhang P, Zhao X. A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/MS. Mol Cell Biochem 2010;343(1-2):91-9.
15. Seam N, Gonzales DA, Kern SJ, Hortin GL, Hoehn GT, Suffredini AF. Quality control of serum albumin depletion for proteomic analysis. Clin Chem 2007; 53(11):1915-20. (Pubitemid 350036035)
16. Shin S, Cazares L, Schneider H, Mitchell S, Laronga C, Semmes OJ, et al. Serum biomarkers to differentiate benign and malignant mammographic lesions. J Am Coll Surg 2007;204(5):1065-71. (Pubitemid 46661204)
17. Navaglia F, Fogar P, Basso D, Greco E, Padoan A, Tonidandel L, et al. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry. Clin Chem Lab Med 2009;47(6): 713-23.
18. Delbeke D, Martin WH. PET and PET/CT for pancreatic malignancies. Surg Oncol Clin N Am 2010;19(2):235-54.
19. Wang F, Kumagai-Braesch M, Herrington MK, Larsson J, Permert J. Increased lipid metabolism and cell turnover of MiaPaCa2 cells induced by high-fat diet in an orthotopic system. Metabolism 2009;58(8):1131-6.
20. Cao WM, Murao K, Imachi H, Yu X, Abe H, Yamauchi A, et al. A mutant highdensity lipoprotein receptor inhibits proliferation of human breast cancer cells. Cancer Res 2004;64(4):1515-21. (Pubitemid 38235625)